A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. In: ASH Annual Meeting Abstracts 2011. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, (1700-1700). Dec 10-13, 2011.

Author Mollee, Peter
Tiley, Campbell
Cunningham, Ilona
Moore, John
Prince, Miles
Cannell, Paul
Gibbons, Steve
Tate, Jill
Paul, Sanjoy
Gill, Devinder S.
Title of paper A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis
Conference name 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)
Conference location San Diego, CA, United States
Conference dates Dec 10-13, 2011
Proceedings title ASH Annual Meeting Abstracts 2011   Check publisher's open access policy
Journal name Blood   Check publisher's open access policy
Place of Publication Washington, DC, United States
Publisher American Society of Hematology
Publication Year 2011
Sub-type Published abstract
Open Access Status Not Open Access
ISSN 0006-4971
1528-0020
Volume 118
Issue 21
Start page 1700
End page 1700
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status UQ
Additional Notes Abstract 3973

Document type: Conference Paper
Collections: Temporary Review
School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Tue, 13 Mar 2012, 18:47:36 EST by System User on behalf of School of Public Health